ICSE China 2019, hosted by CCCMHPIE, UBM EMEA, and UBM Sinoexpo, will take place again in Hall E2/E7...
Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company has announced that it has bee...
I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...
Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company, has been granted an exclusiv...
Gan & Lee Pharmaceuticals (Gan & Lee), an industry leading biopharmaceutical company with 20 years’ experi...
Singapore - Align Technology announced that over 6 million patients have begun treatment with Invisalign - the most...
Pall Corporation, the global leader of advanced filtration, separation and purification technologies, has established a ...
Cellular Biomedicine Group, a biopharmaceutical firm engaged in the development of immunothera...
Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...
Singapore - 2019 ENMORE BIO CONFERENE will be held on 1st-3rd, March, 2019 in Nanjing Young Cultural Center, Nanjing, Ch...
Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, has e...
I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company focused on the development of innov...
The bio-pharma display platform with 7 years of experience in China, BioPh China, will be newly...
Innovent Biologics, Inc. and Incyte have entered into a strategic collaboration agreement for three clinical-stage produ...
Lonza has announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza...
Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commerci...
The government of the city of Wusu (Xinjiang, China) and Cathay Industrial Biotech Co., Ltd. ("Cathay") signed an a...
Singapore – OUE Lippo Healthcare Limited announced that it has entered into a non-binding letter of intent wi...
